Physician profile
Meredith E Sloan
NPI 1215460555
$10,838.56
in general payments reported to CMS, 2019-2025
33 companies · $2,742 in 2025
The $2,742 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $11.48 · 2021: $342 · 2022: $1,277 · 2023: $1,209 · 2024: $5,023 · 2025: $2,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,048 · Education: $2,595 · Travel and Lodging: $1,130 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,048.09 |
| Education | $2,595.23 |
| Travel and Lodging | $1,130.31 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,685.46 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,161.62 | 2021-2025 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $700.97 | 2021-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $646.61 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Pfizer INC. | $540.87 | 2019-2025 | |
| Abbvie INC. | $514.77 | 2021-2025 | Avycaz, Teflaro |
| Mallinckrodt Hospital Products INC. | $393.46 | 2022-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $369.69 | 2021-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $356.11 | 2021-2025 | |
| Genzyme Corporation | $284.04 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $276.87 | 2022-2025 | Zerbaxa, Winrevair, Recarbrio |
| United Therapeutics Corporation | $222.17 | 2022-2025 | Remodulin, Tyvaso, Tyvaso |
| Inari Medical, INC. | $212.29 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $168.57 | 2025 | Clottriever Bold Catheter |
| Pulmonx Corporation | $159.76 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $158.93 | 2022-2025 | Arikayce |
| Ani Pharmaceuticals, INC. | $128.87 | 2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $108.80 | 2022-2025 | Glassia |
| Amgen INC. | $102.79 | 2025 | Imdelltra (Amg757) |
| Mallinckrodt Enterprises LLC | $97.06 | 2019 | |
| La Jolla Pharmaceutical Company | $83.91 | 2019-2025 | Giapreza |
| Janssen Pharmaceuticals, INC | $81.12 | 2024 | Xarelto |
| Ambu INC. | $70.59 | 2025 | |
| Verona Pharma, INC. | $54.94 | 2025 | Ohtuvayre |
| Getinge USA Sales, LLC | $44.48 | 2024 | Base Unit Servo-U |
| Astellas Pharma US INC | $43.70 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $41.41 | 2025 | Uptravi, Opsumit |
| Grifols USA, LLC | $39.99 | 2025 | Prolastin-C Liquid |
| Vapotherm INC | $23.62 | 2022 | |
| Baxter Healthcare | $20.97 | 2024 | Hillrom - Life 2000 Ventilation System |
| Livanova USA, INC. | $18.50 | 2022 | |
| Avanos Medical | $14.14 | 2021 | |
| Novo Nordisk INC | $11.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Sloan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.